Characterization of benign and malignant breast lesions with computed tomography laser mammography (CTLM): initial experience.
about
Optical imaging for breast cancer prescreening.Imaging heterogeneous absorption distribution of advanced breast cancer by optical tomography.Early-stage invasive breast cancers: potential role of optical tomography with US localization in assisting diagnosisOptical imaging in breast cancer diagnosis: the next evolutionDiffuse optical tomography of the breast: initial validation in benign cystsA novel fluorescent imaging agent for diffuse optical tomography of the breast: first clinical experience in patients.A multichannel time-domain scanning fluorescence mammograph: performance assessment and first in vivo results.Diagnostic performance of a Near-Infrared Breast Imaging system as adjunct to mammography versus X-ray mammography alone.Optical tomography method that accounts for tilted chest wall in breast imaging.Radiologic and near-infrared/optical spectroscopic imaging: where is the synergy?Artifact reduction method in ultrasound-guided diffuse optical tomography using exogenous contrast agents.Clustered targets imaged by optical tomography guided by ultrasound.Depth-correction algorithm that improves optical quantification of large breast lesions imaged by diffuse optical tomography.Optical imaging with her2-targeted affibody molecules can monitor hsp90 treatment response in a breast cancer xenograft mouse modelOptimal probing of optical contrast of breast lesions of different size located at different depths by US localization.Computer-Assisted Diagnosis System for Breast Cancer in Computed Tomography Laser Mammography (CTLM).Diffuse optical imaging and spectroscopy for cancer.Noninvasive monitoring of breast cancer during neoadjuvant chemotherapy using optical tomography with ultrasound localization.Optical imaging of the breastNear-infrared imaging of breast cancer using optical contrast agents.Differentiation of angiogenic burden in human cancer xenografts using a perfusion-type optical contrast agent (SIDAG).
P2860
Q26801115-278130A3-810D-4801-9E52-9FC28ED09253Q30472184-83F2F4B7-2860-480F-A78E-3BE5CB9AC471Q30474688-8B4E5E0C-EC39-400D-B21A-E3DE62081F0FQ30585402-C7D377D8-9C7A-4C10-893B-FEC0B6A1A2D2Q33386917-2F246D26-0967-482F-B194-9ACF2262881EQ33831013-A582DB3C-D480-42FA-A3E4-C8E0E45210BBQ33832903-65D5F787-EE54-428F-A3EB-AFE96664097BQ34030538-E13B4721-1270-4792-A7C7-6F6FF96A55F9Q34031680-5DF3F473-4DE9-4548-A874-E36B69A3F2B9Q34357133-185720A8-5990-4284-B91D-BD959B688742Q34981131-31E35725-E3FE-4FD2-AEC0-C20D92161710Q35158003-BC5248AF-6EF7-4EA8-B2FC-23292C64FCF4Q35284140-D551718E-C1DB-49F9-9FAD-F59E3516A04BQ35784634-E21139B8-39EA-465E-B1B4-E3D1CD4CFFDFQ36059661-0962A839-1349-4297-A8B9-ED9FE04DAA80Q36353050-A37EF73D-CBE5-4D72-94E7-FCBC9440EE68Q36691703-622E31E6-C69C-495C-98BC-8BBA76CD075EQ36897823-3D488055-FC3D-4ADC-96F9-BDF20E1B9181Q36990563-526F08CE-5F58-4C9B-909F-31F34D49DCD3Q38058281-5D445FD6-FF8C-47A4-93B3-7FE01F2647ACQ38632004-C84C416C-797A-4E12-9E86-66E8AAA7B0A7
P2860
Characterization of benign and malignant breast lesions with computed tomography laser mammography (CTLM): initial experience.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Characterization of benign and ...... hy (CTLM): initial experience.
@ast
Characterization of benign and ...... hy (CTLM): initial experience.
@en
type
label
Characterization of benign and ...... hy (CTLM): initial experience.
@ast
Characterization of benign and ...... hy (CTLM): initial experience.
@en
prefLabel
Characterization of benign and ...... hy (CTLM): initial experience.
@ast
Characterization of benign and ...... hy (CTLM): initial experience.
@en
P2093
P1476
Characterization of benign and ...... hy (CTLM): initial experience.
@en
P2093
Christopher C Riedl
Daniel Floery
Michael H Fuchsjaeger
Michael Weber
Sepp Leodolter
Silvia Jaromi
Thomas H Helbich
P304
P356
10.1097/01.RLI.0000164487.60548.28
P577
2005-06-01T00:00:00Z